Characterisation of Aspergillus fumigatus Endocytic Trafficking within Airway Epithelial Cells Using High-Resolution Automated Quantitative Confocal Microscopy
- PMID: 34200399
- PMCID: PMC8229978
- DOI: 10.3390/jof7060454
Characterisation of Aspergillus fumigatus Endocytic Trafficking within Airway Epithelial Cells Using High-Resolution Automated Quantitative Confocal Microscopy
Abstract
The precise characterization of the mechanisms modulating Aspergillus fumigatus survival within airway epithelial cells has been impaired by the lack of live-cell imaging technologies and user-friendly quantification approaches. Here we described the use of an automated image analysis pipeline to estimate the proportion of A. fumigatus spores taken up by airway epithelial cells, those contained within phagolysosomes or acidified phagosomes, along with the fungal factors contributing to these processes. Coupling the use of fluorescent A. fumigatus strains and fluorescent epithelial probes targeting lysosomes, acidified compartments and cell membrane, we found that both the efficacy of lysosome recruitment to phagosomes and phagosome acidification determines the capacity of airway epithelial cells to contain A. fumigatus growth. Overall, the capability of the airway epithelium to prevent A. fumigatus survival was higher in bronchial epithelial than alveolar epithelial cells. Certain A. fumigatus cell wall mutants influenced phagosome maturation in airway epithelial cells. Taken together, this live-cell 4D imaging approach allows observation and measurement of the very early processes of A. fumigatus interaction within live airway epithelial monolayers.
Keywords: Aspergillus fumigatus; airway epithelial cells; phagocytosis.
Conflict of interest statement
In the past five years, S.G. has received research funds from Pfizer and has been a council member of the International Society of Human and Animal Mycology (ISHAM). Denning and family hold Founder shares in F2G Ltd, a University of Manchester spin-out antifungal discovery company. He acts, or has recently acted, as a consultant to Pulmatrix, Pulmocide, Zambon, iCo Therapeutics, Mayne Pharma, Biosergen, Bright Angel Therapeutics, Cipla and Metis. He sits on the DSMB for a SARS CoV2 vaccine trial. In the last three years, he has been paid for talks on behalf of Dynamiker, Hikma, Gilead, Merck, Mylan and Pfizer. In the last 5 years D.T has received research funds from Gilead Science and has acted as a consultant for OwlStone Medical.
Figures







Similar articles
-
Phagolysosomal Survival Enables Non-lytic Hyphal Escape and Ramification Through Lung Epithelium During Aspergillus fumigatus Infection.Front Microbiol. 2020 Aug 20;11:1955. doi: 10.3389/fmicb.2020.01955. eCollection 2020. Front Microbiol. 2020. PMID: 32973709 Free PMC article.
-
Proteomics of Aspergillus fumigatus Conidia-containing Phagolysosomes Identifies Processes Governing Immune Evasion.Mol Cell Proteomics. 2018 Jun;17(6):1084-1096. doi: 10.1074/mcp.RA117.000069. Epub 2018 Mar 5. Mol Cell Proteomics. 2018. PMID: 29507050 Free PMC article.
-
Aspergillus fumigatus Cell Wall Promotes Apical Airway Epithelial Recruitment of Human Neutrophils.Infect Immun. 2020 Jan 22;88(2):e00813-19. doi: 10.1128/IAI.00813-19. Print 2020 Jan 22. Infect Immun. 2020. PMID: 31767773 Free PMC article.
-
Interactions of Aspergillus fumigatus Conidia with Airway Epithelial Cells: A Critical Review.Front Microbiol. 2016 Apr 7;7:472. doi: 10.3389/fmicb.2016.00472. eCollection 2016. Front Microbiol. 2016. PMID: 27092126 Free PMC article. Review.
-
Aspergillus fumigatus-Host Interactions Mediating Airway Wall Remodelling in Asthma.J Fungi (Basel). 2022 Feb 6;8(2):159. doi: 10.3390/jof8020159. J Fungi (Basel). 2022. PMID: 35205913 Free PMC article. Review.
Cited by
-
Respiratory Epithelial Cells: More Than Just a Physical Barrier to Fungal Infections.J Fungi (Basel). 2022 May 24;8(6):548. doi: 10.3390/jof8060548. J Fungi (Basel). 2022. PMID: 35736031 Free PMC article. Review.
-
Use of a human small airway epithelial cell line to study the interactions of Aspergillus fumigatus with pulmonary epithelial cells.mSphere. 2023 Oct 24;8(5):e0031423. doi: 10.1128/msphere.00314-23. Epub 2023 Aug 14. mSphere. 2023. PMID: 37578262 Free PMC article.
-
Surrogate infection model predicts optimal alveolar macrophage number for clearance of Aspergillus fumigatus infections.NPJ Syst Biol Appl. 2023 Apr 10;9(1):12. doi: 10.1038/s41540-023-00272-x. NPJ Syst Biol Appl. 2023. PMID: 37037824 Free PMC article.
-
Distinct Cohorts of Aspergillus fumigatus Transcription Factors Are Required for Epithelial Damage Occurring via Contact- or Soluble Effector-Mediated Mechanisms.Front Cell Infect Microbiol. 2022 Jul 28;12:907519. doi: 10.3389/fcimb.2022.907519. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35982778 Free PMC article.
-
Pathogenicity and virulence of Aspergillus fumigatus.Virulence. 2023 Dec;14(1):2172264. doi: 10.1080/21505594.2023.2172264. Virulence. 2023. PMID: 36752587 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources